Pharm, PhDUniversité Paris Cité, Inserm UMR-S 1140, Hématologie biologique, Hôpital Lariboisière (AP-HP)Paris, Ile-de-France, France
PB0033 - Apixaban population pharmacokinetic model in very elderly patients with atrial fibrillation (ADAGE study): a useful tool to predict plasma concentration decrease in case of urgent invasive procedure
Sunday, June 23, 202413:45 – 14:45 ICT
PB0034 - Assessment of fibrinography and thrombography variability using Thrombodynamics-4D in patients ≥ 80 years receiving DOAC (rivaroxaban, apixaban, dabigatran) for atrial fibrillation
